Chen Mingqi, Kang Xuya, Zhang Yan, Liu Yahan
Institute of Cardiovascular Sciences, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
Br J Pharmacol. 2024 Jun 2. doi: 10.1111/bph.16472.
Cardiovascular diseases are significant contributors to human mortality, closely associated with inflammation. With the changing living conditions and the extension of human lifespan, greater attention has been directed towards understanding the impact of early, long-term events on the development of cardiovascular events. Lifestyle factors such as stress, unhealthy diet and physical inactivity can increase the risk of cardiovascular diseases. Interestingly, even if the risk factors are addressed later, their influence may persist. Recently, the concept of trained innate immunity (TRIM), defined as sustained alterations in the function of innate immunocyte that promote a more robust response to downstream stimuli, has been proposed to be involved in cardiovascular diseases. It is hypothesized that TRIM may serve as a mediator bridging the impacts of aforementioned risk factors. This review aims to elucidate the role of TRIM in cardiovascular diseases and highlight its significance in uncovering new mechanisms and therapeutic targets.
心血管疾病是导致人类死亡的重要因素,与炎症密切相关。随着生活条件的改变和人类寿命的延长,人们越来越关注早期长期事件对心血管疾病发生发展的影响。压力、不健康饮食和缺乏体育锻炼等生活方式因素会增加心血管疾病的风险。有趣的是,即使这些风险因素在之后得到解决,其影响可能依然存在。最近,有人提出训练有素的固有免疫(TRIM)这一概念,即固有免疫细胞功能的持续改变,可促进对下游刺激产生更强有力的反应,该概念被认为与心血管疾病有关。据推测,TRIM可能作为一种介质,在上述风险因素的影响之间起桥梁作用。本综述旨在阐明TRIM在心血管疾病中的作用,并强调其在揭示新机制和治疗靶点方面的重要性。